
Bioscience, Biotechnology and Biochemistry p. 1740 - 1741 (1995)
Update date:2022-08-02
Topics:
Okamoto
Ueda
Takahashi
Nakazawa
Doi
The enantiomeric separation of SM-10661, a platelet activating factor receptor antagonist, was investigated by HPLC using ligand-exchange chiral stationary phases. The stereoisomers of SM-10661 could all be separated by ligand-exchange HPLC with a Cu(II) N,S-dioctyl-D-penicillamine complex (Sumichiral OA-5000). The mechanism for the resolution includes the involvement of hydrophobic interactions between SM-10661 and Cu(II) D-penicillamine.
View MoreContact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Nanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Shaanxi HuaTai Bio-fine chemical company Ltd
Contact:86-029-87862197
Address:No. 5, 3rd Floor, 29 Yanta North Road, Beilin Dist.
Doi:10.1021/jm00124a016
(1989)Doi:10.1016/j.tetlet.2009.08.015
(2009)Doi:10.1016/j.ica.2009.07.008
(2009)Doi:10.1021/ja00190a034
(1989)Doi:10.1080/00397910902840827
(2009)Doi:10.1016/S0020-1693(00)89284-1
(1989)